E.coli-derived human RIMKLA recombinant protein (Position: Q19-K391).
Alternative Names:
RIMKLA, FAM80A, N-acetylaspartylglutamate synthase A, NAAG synthetase A, NAAGS, N-acetylaspartylglutamylglutamate synthase A, Ribosomal protein S6 modification-like protein A
Each vial contains 50% glycerol, 0.9% NaCl, 0.2% Na2HPO4.
Purity:
Immunogen affinity purified.
Form:
Liquid
Target:
N-acetylaspartylglutamate synthase A
Application Dilute:
Western blot, Optimal dilutions should be determined by end users. Immunohistochemistry (Paraffin-embedded Section), Optimal dilutions should be determined by end users. ELISA, Optimal dilutions should be determined by end users.
* VAT and and shipping costs not included. Errors and price changes excepted